News
An agreement signed between SERGAS, and the Precision Cancer Consortium seeks to accelerate the implementation of CGP for...
"Our vision is to make precision oncology and CGP the new normal – only together can we achieve this." A message from Precision...
The Pathway to Precision Cancer Care: A Strategic and Operational Guide to Enhance Patient Access to CGP
Professor Hofman discussed how liquid biopsy has become an essential component of molecular testing in aNSCLC.
Lean Six Sigma is an approach to laboratory workflow optimization to improve diagnostic testing turnaround time and quality....
PCC has bolstered its membership with the addition of Bristol Myers Squibb (BMS).
These 10-minute expert-led videos highlight the vital role of pathologists in the success of clinical studies.
A Scientific Steering Committee, featuring leading oncologist and pathologist key opinion leaders, was held on Friday, May...
We’re pleased to share that the Precision Cancer Consortium (PCC) has been shortlisted for the Precision Medicine Awards...
The PCC, along with IQVIA, have redeveloped the genomic testing cost calculator to incorporate testing costs in USD.
"Our vision is to make precision oncology and CGP the new normal – only together can we achieve this." A message from Precision...
PCC has initiated a new project with healthcare specialists Avalere Health to drive the implementation of Comprehensive Genomic...
A key mission of the Precision Cancer Consortium’s (PCC) education and awareness workstream is to uncover the challenges...
PCC has initiated a new and exciting project with strategy consulting specialists DeciBio
June 2024, ASCO Annual Meeting, Chicago – The Precision Cancer Consortium (PCC), in partnership with Massive Bio, has unveiled...